↓ Skip to main content

Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate

Overview of attention for article published in BMC Medicine, January 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
6 news outlets
twitter
112 tweeters
facebook
4 Facebook pages
wikipedia
1 Wikipedia page
googleplus
1 Google+ user
reddit
1 Redditor

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
80 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Is statin-modified reduction in lipids the most important preventive therapy for cardiovascular disease? A pro/con debate
Published in
BMC Medicine, January 2016
DOI 10.1186/s12916-016-0550-5
Pubmed ID
Authors

FD Richard Hobbs, Maciej Banach, Dimitri P. Mikhailidis, Aseem Malhotra, Simon Capewell

Abstract

The most prescribed medications in the world are statins, lipid modifiers that have been available for over 25 years and amongst the most investigated of all drug classes. With over a million patient years of trial data and publications in the most prestigious medical journals, it is remarkable that quite so much debate remains as to their place in healthcare. They have had a bittersweet passage, with vocal concerns over their possible risks, from suicide to cancer, and allegations that they do not work in women or the elderly, to statements that the whole published dataset, on over 200,000 patients consenting to enter trials, was fatally compromised by being industry-funded by and large. On the other side, there have been billions of dollars spent on generating their evidence base followed by promotion which has returned that investment many times over in profits, and a powerful scientific lobby that argue they are wonder drugs and that continued nihilism on their value risks patient lives. So who is right?

Twitter Demographics

The data shown below were collected from the profiles of 112 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 80 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 1%
United States 1 1%
Unknown 78 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 16%
Other 11 14%
Student > Bachelor 10 13%
Student > Master 9 11%
Student > Ph. D. Student 8 10%
Other 18 23%
Unknown 11 14%
Readers by discipline Count As %
Medicine and Dentistry 36 45%
Biochemistry, Genetics and Molecular Biology 7 9%
Pharmacology, Toxicology and Pharmaceutical Science 6 8%
Nursing and Health Professions 3 4%
Psychology 2 3%
Other 10 13%
Unknown 16 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 119. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 May 2020.
All research outputs
#214,494
of 18,217,263 outputs
Outputs from BMC Medicine
#186
of 2,774 outputs
Outputs of similar age
#5,248
of 380,453 outputs
Outputs of similar age from BMC Medicine
#26
of 296 outputs
Altmetric has tracked 18,217,263 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,774 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 39.3. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 380,453 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 296 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.